Literature DB >> 9833699

Does smoking stimulate rheumatoid factor production in non-rheumatic individuals?

T Jónsson1, J Thorsteinsson, H Valdimarsson.   

Abstract

Smoking has been associated with increased incidence of rheumatoid arthritis (RA), joint damage and positive rheumatoid factor (RF). Here we report an analysis of the association between smoking and IgM, IgG and IgA RF in a cohort of non-rheumatic individuals participating in a prospective longitudinal study of the incidence and significance of elevated RF. From the initial cohort of nearly 14,000 randomly selected individuals aged 52-80 years, 109 RF-positive and 187 RF-negative non-rheumatic participants were recruited. All participants were tested for RF at least twice at an interval ranging from 4 to 13 years. Of the RF-negative participants 21.9% were active smokers compared to 34.1% of IgM RF-positive (p=0.035), 20.8% of IgG RF-positive (N.S.) and 34.4% of IgA RF-positive participants (p=0.047). Smoking was most prevalent (44.8%) amongst participants with elevation of both IgM and IgA RF (p=0.008), and smokers were also significantly more likely to have a persistent elevation of RF than non-smokers (p=0.024). These findings indicate that smoking may influence the immune system, leading to increased production of IgM and IgA RF.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9833699     DOI: 10.1111/j.1699-0463.1998.tb00247.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  23 in total

1.  Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus.

Authors:  M M Freemer; T E King; L A Criswell
Journal:  Ann Rheum Dis       Date:  2005-09-08       Impact factor: 19.103

2.  Cigarette smoking and the risk of systemic lupus erythematosus and rheumatoid arthritis.

Authors:  D S Majka; V M Holers
Journal:  Ann Rheum Dis       Date:  2006-05       Impact factor: 19.103

3.  Rheumatoid arthritis-associated autoantibodies and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Elana J Bernstein; R Graham Barr; John H M Austin; Steven M Kawut; Ganesh Raghu; Jessica L Sell; Eric A Hoffman; John D Newell; Jubal R Watts; P Hrudaya Nath; Sushil K Sonavane; Joan M Bathon; Darcy S Majka; David J Lederer
Journal:  Thorax       Date:  2016-09-08       Impact factor: 9.139

4.  Increased inflammation and disease activity among current cigarette smokers with rheumatoid arthritis: a cross-sectional analysis of US veterans.

Authors:  Jeremy Sokolove; Catriona A Wagner; Lauren J Lahey; Harlan Sayles; Michael J Duryee; Andreas M Reimold; Gail Kerr; William H Robinson; Grant W Cannon; Geoffrey M Thiele; Ted R Mikuls
Journal:  Rheumatology (Oxford)       Date:  2016-07-31       Impact factor: 7.580

5.  Comorbidity and lifestyle, reproductive factors, and environmental exposures associated with rheumatoid arthritis.

Authors:  A Reckner Olsson; T Skogh; G Wingren
Journal:  Ann Rheum Dis       Date:  2001-10       Impact factor: 19.103

6.  Perinatal and early childhood risk factors associated with rheumatoid factor positivity in a healthy paediatric population.

Authors:  Kendra A Young; Lezlie A Parrish; Gary O Zerbe; Marian Rewers; Kevin D Deane; V Michael Holers; Jill M Norris
Journal:  Ann Rheum Dis       Date:  2007-02       Impact factor: 19.103

7.  Disease progression and treatment responses in a prospective DMARD-naive seropositive early rheumatoid arthritis cohort: does gender matter?

Authors:  Damini Jawaheer; Paul Maranian; Grace Park; Maureen Lahiff; Sogol S Amjadi; Harold E Paulus
Journal:  J Rheumatol       Date:  2010-10-01       Impact factor: 4.666

8.  Effect of rheumatoid factor on mortality and coronary heart disease.

Authors:  Gunnar Tomasson; Thor Aspelund; Thorbjorn Jonsson; Helgi Valdimarsson; David T Felson; Vilmundur Gudnason
Journal:  Ann Rheum Dis       Date:  2009-07-23       Impact factor: 19.103

Review 9.  Update on autoantibodies in rheumatoid arthritis.

Authors:  S Louis Bridges
Journal:  Curr Rheumatol Rep       Date:  2004-10       Impact factor: 4.592

10.  Circulating anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis and chronic obstructive pulmonary disease.

Authors:  Deng-Ho Yang; Chuan-Chou Tu; Shou-Cheng Wang; Cheng-Chung Wei; Ya-Wen Cheng
Journal:  Rheumatol Int       Date:  2013-12-24       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.